These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2905326)

  • 1. [Diabetes and hyperlipidemia. Increased coronary risk can be prevented].
    Fortschr Med Suppl; 1988; 46():14-5. PubMed ID: 2905326
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hyperlipidemia in diabetes mellitus and hypertension].
    Krone W
    Verh Dtsch Ges Inn Med; 1989; 95():636-8. PubMed ID: 2603499
    [No Abstract]   [Full Text] [Related]  

  • 3. [Three of four diabetics die of coronary heart disease. What permits sweet heart to beat longer?].
    Tschöpe D
    MMW Fortschr Med; 2001 Nov; 143(44):14. PubMed ID: 11732389
    [No Abstract]   [Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease.
    Tenenbaum A; Motro M; Fisman EZ; Schwammenthal E; Adler Y; Goldenberg I; Leor J; Boyko V; Mandelzweig L; Behar S
    Circulation; 2004 May; 109(18):2197-202. PubMed ID: 15123532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C; Olsson AG
    Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerance of 400 MG bezafibrate in diabetic and hyperlipidaemic patients.
    Lakatos J; Molnár M; Tóth K
    Acta Physiol Hung; 1996; 84(4):433-5. PubMed ID: 9328624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninsulin dependent diabetes mellitus.
    Florkowski CM; Lintott CJ; Scott RS
    N Z Med J; 1993 Mar; 106(952):110. PubMed ID: 8474719
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heart function and heart disease in diabetes mellitus].
    Thuesen L; Dybdahl H; Gøtzsche O; Christiansen JS
    Ugeskr Laeger; 1988 Jan; 150(1):4-6. PubMed ID: 3287714
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of bezafibrate in patients with combined hyperlipidemia].
    Vílchez Joya R; Escobar Jiménez F; Campos MM; Torres E; Orduña R; Cabrera J; Núñez J
    Med Clin (Barc); 1986 Feb; 86(5):190-4. PubMed ID: 3959651
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dyslipidemia of diabetes and insulin resistance].
    Halimi S
    Nephrologie; 2000; 21(7):345-6. PubMed ID: 11200607
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lipid disorders in non-insulin dependent diabetes--principles of treatment].
    Idzior-Waluś B
    Przegl Lek; 1996; 53(9):653-9. PubMed ID: 8992531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is pseudocholinesterase activity related to markers of triacylglycerol synthesis in Type II diabetes mellitus?
    Rustemeijer C; Schouten JA; Voerman HJ; Beynen AC; Donker AJ; Heine RJ
    Clin Sci (Lond); 2001 Jul; 101(1):29-35. PubMed ID: 11410111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipidemia in diabetes. A comprehensive analysis.
    Larsen JL
    Adv Nurse Pract; 1998 Apr; 6(4):36-43. PubMed ID: 9611482
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperlipidemia in children with type 2 diabetes mellitus.
    Taha D
    J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():505-7. PubMed ID: 12017224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood glucose and coronary heart disease.
    Elkeles RS
    Eur Heart J; 2000 Nov; 21(21):1735-7. PubMed ID: 11052836
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lipid disorders in patients with diabetes].
    Ciechanowski K; Pynka S
    Przegl Lek; 1996; 53(9):660-2. PubMed ID: 8992532
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus: a study utilizing the revised diagnostic criteria.
    de Andino RM; Mendoza M; Vera M; Martínez V
    Bol Asoc Med P R; 1988 Feb; 80(2):48-50. PubMed ID: 3348881
    [No Abstract]   [Full Text] [Related]  

  • 19. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia.
    Milicevic Z; Raz I; Beattie SD; Campaigne BN; Sarwat S; Gromniak E; Kowalska I; Galic E; Tan M; Hanefeld M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S155-60. PubMed ID: 18227478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of drug-eluting stents in coronary heart disease treatment with emphasis on the diabetic subgroup.
    Nguyen MC; Lim YL
    Heart Lung Circ; 2007 Feb; 16(1):7-9. PubMed ID: 17169611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.